Naltrexone (drug)

DRUG2 trials

Sponsors

University of Chicago, Central Institute of Mental Health, Mannheim

Conditions

Alcohol AddictionAlcoholismSmokingSmoking Cessation

Phase 2

Efficacy of Naltrexone in Women's Smoking Cessation

CompletedNCT00271024

University of ChicagoSmoking, Smoking Cessation

Start: 2005-12-31End: 2010-03-31Updated: 2023-03-23

A Trial to Investigate the Effects of Cannabidiol Plus Naltrexone on Alcohol Craving in Patients With Alcohol Dependence

RecruitingNCT06845124

Central Institute of Mental Health, MannheimAlcohol Addiction, Alcoholism

Start: 2025-07-22End: 2028-09-30Target: 150Updated: 2026-02-03

Related Papers

Investigation of the combined effects of cannabidiol plus naltrexone on alcohol craving in alcohol dependence: study protocol of a phase II randomised, double-blind, placebo-controlled, parallel-group trial – ICONICplus Trial

BMJ Open2025-08-01